Recent Finacing
Recent Raise
Tarsa Therapeutics develops OSTORA, an oral calcitonin formulation for treatment and prevention of postmenopausal osteoporosis, holding exclusive global commercialization rights (ex-China) and conducting Phase III and regulatory filings.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors